News | Cath Lab | August 22, 2016

DMC Heart Hospital Completes Complex High-Risk Indicated Interventional Procedure Course

Veteran interventional cardiologists and DMC Heart Hospital leadership offered four clinically complex PCI cases via live feed during the course

DMC Heart Hospital, Detroit Medical Center, complex percutaneous intervention education course, PCI, cath lab training

August 22, 2016 — The Detroit Medical Center (DMC) Heart Hospital recently completed a Complex Percutaneous Intervention education course, utilizing an unprecedented four live, clinically complex cases. Participating physicians included: DMC Heart Hospital President Theodore Schreiber, M.D.; Vice President Cindy Grines, M.D.,; Medical Director of the Cardiac Care Unit and Chief of Cardiology Mahir Elder, M.D.; Cardiac Catheterization Lab Medical Director Amir Kaki, M.D.; and Tamam Mohamad, M.D.

The Complete Revascularization of Higher Risk Patients (frequently abbreviated as “CHIP”) program is geared toward the interventionalist seeking to better understand complex percutaneous coronary intervention (PCI) in the modern era. Presentations address treatment of left main disease, chronic total occlusions, long lesions, bifurcation lesions, “small vessels” and saphenous vein grafts. In addition, participants learn how to manage challenging patient subsets, such as those with advanced heart failure, as well as how to provide optimal hemodynamic support.

The course is a combination of live complex cases, hands-on workstations and didactic. DMC provided four live complex cases; traditionally, most accounts only do one or two live cases. The cases are displayed via live video feed from the cardiac catheterization lab to the education room.

This course educated interventional physicians on an option for patients that are too sick for surgery or refuse surgery. By training other interventional cardiologists on why, how and which patients are U.S. Food and Drug Administration (FDA)-indicated for supported PCI, more heart failure patients can be treated effectively, versus being sent home on medical management. Additionally, the data shows when treated by supported PCI, these patients stay in the hospital for a shorter periods of time, they feel better once they leave and they experience less readmissions.

“No other Complex PCI CHIP course has ever demonstrated four live cases as complex as the ones showcased on Monday,” according to Schreiber. “However, it is not only the case complexity and the positive outcomes achieved, but the ability to engage the audience with questions, knowledge, charm and even some humor, which makes this course an impactful and memorable experience for all.”

For more information: www.dmc.org

Related Content

Philips Healthcare, Volcano IVUS showing an implanted stent. IVUS might offer an alternative to contrast angiography in patients with acute kidney disease (AKD).
News | Cath Lab | June 14, 2019
June 14, 2019 – A late-breaking study examined the effects of intravascular ultrasound (IVUS) guided drug-eluting ste
Videos | Cath Lab | May 20, 2019
This is a walk through of the primary structural heart hybrid cath lab at...
Mobility May Predict Elderly Heart Attack Survivors' Repeat Hospital Stays
News | Cath Lab | April 23, 2019
Determining which elderly heart attack patients take longer to stand from a seated position and walk across a room may...
FDA Releases New Guidance on Medical Devices Containing Nitinol
News | Cath Lab | April 18, 2019
April 18, 2019 — The U.S.
Angiography shows a stenotic lesion in the mid right coronary artery, undilatable by standard high-pressure balloon angioplasty (inset, arrowheads). (B) Optical coherence tomography (OCT) cross-sectional (top) and longitudinal (bottom) images acquired before IVL and coregistered to the OCT lens (arrow in A) demonstrate severe near-circumferential calcification in the area of the stenosis. (C) Angiography demonstrates improvement in the area of stenosis after IVL lithoplasty.

Figure 2: Angiography demonstrates a stenotic lesion in the mid right coronary artery, undilatable by standard high-pressure balloon angioplasty (inset, arrowheads). (B) Optical coherence tomography (OCT) cross-sectional (top) and longitudinal (bottom) images acquired before IVL and coregistered to the OCT lens (arrow in A) demonstrate severe near-circumferential calcification (double-headed arrow) in the area of the stenosis. (C) Angiography demonstrates improvement in the area of stenosis after IVL (inset; note the cavitation bubbles generated by IVL [black arrows]). (D) OCT cross-sectional (top) and longitudinal (bottom) images acquired post-IVL and coregistered to the OCT lens (white arrow in C) demonstrate multiple calcium fractures and large acute luminal gain. (E) Angiography demonstrates complete stent expansion with the semicompliant stent balloon (inset) without the need for high-pressure noncompliant balloon inflation. (F) OCT cross-sectional (top) and longitudinal (bottom) images acquired post-stenting and coregistered to the OCT lens (arrow in E) demonstrate further fracture displacement (arrow), with additional increase in the acute area gain (5.17 mm2), resulting in full stent expansion and minimal malapposition.

Feature | Cath Lab | April 15, 2019 | Dean Kereiakes, M.D., FACC, FSCAI, and Jonathan Hill, M.D., DISRUPT CAD III Co-Principal Investigators
Over the last 40 years, despite multiple advancements in percutaneous coronary interventions, calcified lesions remai
BIOTRONIK’s PK Papyrus covered coronary stent. The stent ius used in emergency coronary artery dissections to repair the vessel wall.
Technology | Cath Lab | April 15, 2019
April 15, 2019 — Biotronik began its U.S.
Providing Follow-Up Care After Heart Attack Helps Reduce Readmissions, Deaths
News | Cath Lab | April 09, 2019
A program designed to help heart attack patients with the transition from hospital to outpatient care can reduce...
TherOx Receives FDA Approval for SuperSaturated Oxygen Therapy
Technology | Cath Lab | April 08, 2019
TherOx Inc. announced that the U.S. Food and Drug Administration (FDA) granted premarket approval for its...
Cook Medical Recalls Transseptal Needle Due to Risk of Detached Plastic Fragments
News | Cath Lab | March 20, 2019
March 20, 2019 — Cook Medical is recalling one lot of its...
Overlay Init